Celltrion, “We’re preparing for the U.S. FDA’s onsite inspection for our first global generic”
In response to the Korea Exchange’s request of inquiry notice on the 17th, Celltrion officially announced on the 18th “We carefully reviewed each item on Paragraph 1 of Article 6 of the KOSDAQ’s Posting Regulations and its impacts to stock price and exchange volume, and we have no important infor...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.